The G209a Mutation In The α-synuclein Gene In Brazilian Families With Parkinson's Disease
Teive H.A.G., M H Polymeropoulos(National Institutes of Health), Elizabeth C. LeRoy, Salmo Raskin(Universidade Positivo), Elizabeth Quagliato(Hospital de Clínicas da Unicamp), Germiniani F.M.B., Nasser Allan(Hospital de Base), Baran M.H.H., Lineu César Werneck(Hospital de Clínicas Universidade Federal do Paraná), Fábio M. Iwamoto(Columbia University), Susan Ide(Novartis (United States))
Americanae (AECID Library)
January 1, 2001
Cited by 0
Related Papers
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23
|Science|1996|784
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540